Physician profile
Rajinder Chhokar
NPI 1215039714
$17,139.19
in general payments reported to CMS, 2019-2025
49 companies · $2,059 in 2025
The $2,059 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,397 · 2020: $1,344 · 2021: $2,571 · 2022: $2,338 · 2023: $5,443 · 2024: $1,987 · 2025: $2,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,785 · Travel and Lodging: $2,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,785.02 |
| Travel and Lodging | $2,704.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,066.88 | 2019-2025 | Ensite Precision, Aveir, Cardiomems |
| Janssen Pharmaceuticals, INC | $1,266.33 | 2019-2024 | Xarelto |
| Amgen INC. | $1,262.13 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $1,108.96 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $929.49 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $731.35 | 2019-2025 | Farxiga, Lokelma, Andexxa |
| Merck Sharp & Dohme LLC | $656.09 | 2022-2025 | Verquvo, Capvaxive |
| Esperion Therapeutics, INC. | $636.40 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $612.15 | 2021-2025 | |
| Novo Nordisk INC | $589.89 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $555.19 | 2021-2025 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $383.25 | 2025 | Assure Wcd |
| Amarin Pharma, INC. | $364.62 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $335.55 | 2019-2024 | Jardiance |
| Medtronic, INC. | $300.44 | 2021-2023 | Azure Xt Dr Mri Surescan |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $299.93 | 2020-2025 | Amvuttra, Onpattro |
| Boston Scientific Corporation | $229.38 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, General - Therapies |
| Cvrx, INC. | $207.59 | 2024-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $173.19 | 2019-2020 | |
| Atricure, INC. | $154.48 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $147.26 | 2024 | Impella |
| Lantheus Medical Imaging, INC. | $119.34 | 2021 | |
| Sanofi-Aventis U.S. LLC | $107.71 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.59 | 2019-2021 | |
| Livanova USA, INC. | $72.25 | 2021-2022 | |
| Daiichi Sankyo INC. | $68.04 | 2023-2025 | Injectafer |
| Inspire Medical Systems, INC. | $53.18 | 2024-2025 | Inspire |
| Irhythm Technologies, INC. | $51.80 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Stryker Corporation | $46.46 | 2021 | |
| Gilead Sciences, INC. | $41.67 | 2019 | |
| Terumo Medical Corporation | $39.11 | 2020 | |
| Philips North America LLC | $35.93 | 2022-2023 | |
| Lilly USA, LLC | $33.67 | 2025 | Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals International, Plc | $33.59 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $32.95 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $28.35 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cardiovascular Systems INC. | $24.38 | 2020 | |
| Lundbeck LLC | $24.23 | 2019 | |
| Cardiva Medical, INC. | $24.10 | 2021-2022 | |
| Angiodynamics, INC. | $24.10 | 2021 | |
| Cook Medical LLC | $23.29 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $22.31 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $21.71 | 2023 | Arcalyst |
| Innovation Technologies INC | $20.34 | 2024 | Irrisept |
| Regeneron Healthcare Solutions, INC. | $19.36 | 2023 | Evkeeza |
| Heartflow, INC. | $17.87 | 2024 | |
| Bridgebio Pharma, INC. | $16.89 | 2025 | Attruby |
| Elutia, INC. | $13.66 | 2019 | |
| Amryt Pharma Holdings LTD | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajinder Chhokar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.